Miguel Navasa

6.6k total citations · 1 hit paper
79 papers, 4.6k citations indexed

About

Miguel Navasa is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Miguel Navasa has authored 79 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Hepatology, 42 papers in Surgery and 36 papers in Epidemiology. Recurrent topics in Miguel Navasa's work include Liver Disease and Transplantation (47 papers), Liver Disease Diagnosis and Treatment (29 papers) and Organ Transplantation Techniques and Outcomes (28 papers). Miguel Navasa is often cited by papers focused on Liver Disease and Transplantation (47 papers), Liver Disease Diagnosis and Treatment (29 papers) and Organ Transplantation Techniques and Outcomes (28 papers). Miguel Navasa collaborates with scholars based in Spain, United States and United Kingdom. Miguel Navasa's co-authors include Vicente Arroyo, Juan Rodés, Wladimiro Jiménez, Joan Rodés, Antoni Rimola, Javier Fernández, Juan Carlos García‐Pagán, Jaime Bosch, Ramón Planas and Javier Fernández and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Miguel Navasa

78 papers receiving 4.5k citations

Hit Papers

Hemodynamic events in a prospective randomized trial of p... 1990 2026 2002 2014 1990 100 200 300 400 500

Peers

Miguel Navasa
Miguel Navasa
Citations per year, relative to Miguel Navasa Miguel Navasa (= 1×) peers Lluı́s Castells

Countries citing papers authored by Miguel Navasa

Since Specialization
Citations

This map shows the geographic impact of Miguel Navasa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miguel Navasa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miguel Navasa more than expected).

Fields of papers citing papers by Miguel Navasa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miguel Navasa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miguel Navasa. The network helps show where Miguel Navasa may publish in the future.

Co-authorship network of co-authors of Miguel Navasa

This figure shows the co-authorship network connecting the top 25 collaborators of Miguel Navasa. A scholar is included among the top collaborators of Miguel Navasa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miguel Navasa. Miguel Navasa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kerbert, Annarein, Enric Reverter, Miguel Navasa, et al.. (2018). Impact of hepatic encephalopathy on liver transplant waiting list mortality in regions with different transplantation rates. Clinical Transplantation. 32(11). e13412–e13412. 9 indexed citations
2.
Balderramo, Domingo, Oriol Sendino, Marta Burrel, et al.. (2012). Risk factors and outcomes of failed endoscopic retrograde cholangiopancreatography in liver transplant recipients with anastomotic biliary strictures: A case-control study#. Liver Transplantation. 18(4). 482–489. 13 indexed citations
3.
Pérez‐del‐Pulgar, Sofía, Mairene Coto‐Llerena, Patricia González, et al.. (2011). Cell Culture Replication of a Genotype 1b Hepatitis C Virus Isolate Cloned from a Patient Who Underwent Liver Transplantation. PLoS ONE. 6(8). e23587–e23587. 13 indexed citations
4.
Linares, Laura, Carlos Cervera, Irma Hoyo, et al.. (2010). Klebsiella pneumoniae Infection in Solid Organ Transplant Recipients: Epidemiology and Antibiotic Resistance. Transplantation Proceedings. 42(8). 2941–2943. 52 indexed citations
5.
Fondevila, Constantino, Amelia J. Hessheimer, David G. Calatayud, et al.. (2007). Liver Transplant Using Donors After Unexpected Cardiac Death: Novel Preservation Protocol and Acceptance Criteria. American Journal of Transplantation. 7(7). 1849–1855. 215 indexed citations
6.
Morales‐Ruiz, Manuel, Constantino Fondevila, Javier Muñoz, et al.. (2007). Gene Transduction of an Active Mutant of Akt Exerts Cytoprotection and Reduces Graft Injury After Liver Transplantation. American Journal of Transplantation. 7(4). 769–778. 11 indexed citations
7.
Fernández, Javier, Àngels Escorsell, Michel Zabalza, et al.. (2006). Adrenal insufficiency in patients with cirrhosis and septic shock: Effect of treatment with hydrocortisone on survival. Hepatology. 44(5). 1288–1295. 196 indexed citations
8.
Fernández, Javier, L Ruíz del Arbol, Cristina Gómez, et al.. (2006). Norfloxacin vs Ceftriaxone in the Prophylaxis of Infections in Patients With Advanced Cirrhosis and Hemorrhage. Gastroenterology. 131(4). 1049–1056. 281 indexed citations
9.
Fernández, Javier, Joan Monteagudo, Xavier Bargalló, et al.. (2005). A Randomized Unblinded Pilot Study Comparing Albumin Versus Hydroxyethyl Starch in Spontaneous Bacterial Peritonitis * #. Hepatology. 42(3). 627–634. 169 indexed citations
10.
Charco, R., Josep Martí, Joana Ferrer, et al.. (2005). Mil trasplantes hepáticos en el Hospital Clínic i Provincial de Barcelona. Cirugía Española. 78(4). 231–237. 2 indexed citations
11.
Fernández, Javier, Miguel Navasa, Juan Carlos García‐Pagán, et al.. (2004). Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis. Journal of Hepatology. 41(3). 384–390. 105 indexed citations
12.
Bauer, Tilman, Miguel Navasa, Jordi Vilà, et al.. (2002). Daily Norfloxacin Is More Effective Than Weekly Rufloxacin in Prevention of Spontaneous Bacterial Peritonitis Recurrence. Digestive Diseases and Sciences. 47(6). 1356–1361. 44 indexed citations
13.
Cejudo-Martı́n, Pilar, Josefa Ros Velasco, Miguel Navasa, et al.. (2001). Increased production of vascular endothelial growth factor in peritoneal macrophages of cirrhotic patients with spontaneous bacterial peritonitis. Hepatology. 34(3). 487–493. 32 indexed citations
14.
Cirera, Isabel, Miguel Navasa, Antoni Rimola, et al.. (2000). Ascites after liver transplantation. Liver Transplantation. 6(2). 157–162. 63 indexed citations
15.
Velasco, Josefa Ros, Manuel Morales‐Ruiz, Miguel Navasa, et al.. (1999). Vascular Endothelial Growth Factor Production in Peritoneal Macrophages of Cirrhotic Patients: Regulation by Cytokines and Bacterial Lipopolysaccharide. Hepatology. 29(4). 1057–1063. 60 indexed citations
16.
Ginès, Pere, et al.. (1997). [Current treatment of ascites and spontaneous bacterial peritonitis in Spain: analysis of a survey of gastroenterologists and hepatologists].. PubMed. 20(9). 437–41. 2 indexed citations
17.
Panés, Julián, Joan Caballería, Raimón Guitart, et al.. (1993). Determinants of Ethanol and Acetaldehyde Metabolism in Chronic Alcoholics. Alcoholism Clinical and Experimental Research. 17(1). 48–53. 30 indexed citations
18.
Lacy, Antonio M., Miguel Navasa, Rosa Gilabert, et al.. (1992). Long–Term Effects of Distal Splenorenal Shunt on Hepatic Hemodynamics and Liver Function in Patients With Cirrhosis: Importance of Reversal of Portal Blood Flow. Hepatology. 15(4). 616–622. 22 indexed citations
19.
Groszmann, Roberto J., Jackie Bosch, Norman D. Grace, et al.. (1990). Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology. 99(5). 1401–1407. 537 indexed citations breakdown →
20.
Bosch, Jaume, et al.. (1989). Portal Hypertension. Medical Clinics of North America. 73(4). 931–953. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026